Evidence map›Paper›PMID 35326662›Full record

ArticleCancers2022

Yu-Erh Huang, Ying-Huang Tsai, Yu-Jie Huang, Jr-Hau Lung, Kuo-Wei Ho, Tzu-Chen Yen, Sheng-Chieh Chan, Shu-Tian Chen, Ming-Feng Tsai, Ming-Szu Hung

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. The Predictive Value ofCurrent medical imaging · 2026
    Article
  2. [Research Progress of Anti-lung Cancer Drug-related Interstitial Lung Disease].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2025
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yu-Erh HuangDepartment of Nuclear Medicine, Jen-Ai Hospital, Dali Branch, No. 483, Dong Rong Rd., Dali District, Taichung City 412224, Taiwan.
Ying-Huang TsaiDepartment of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Chiayi Branch, No. 6, Sec. West, Jiapu Rd., Puzi City 613, Chiayi County, Taiwan.
Yu-Jie HuangDepartment of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, No. 123, Dapei Rd., Niaosong Dist., Kaohsiung City 833, Taiwan.
Jr-Hau LungDepartment of Medical Research, Chang Gung Memorial Hospital, Chiayi Branch, No. 6, Sec. West, Jiapu Rd., Puzi City 613, Chiayi County, Taiwan.ORCID 0000-0003-2100-3713
Kuo-Wei HoDepartment of Nuclear Medicine, Chang Gung Memorial Hospital, Chiayi Branch, No. 6, Sec. West, Jiapu Rd., Puzi City 613, Chiayi County, Taiwan.
Tzu-Chen YenDepartment of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, No. 5, Fuxing St., Guishan Dist., Taoyuan City 333, Taiwan.
Sheng-Chieh ChanDepartment of Nuclear Medicine, Hualien Tzu-Chi Hospital, Buddhist Tzu-Chi Medical Foundation, No. 707, Sec. 3, Chung-Yang Rd., Hualien City 970, Taiwan.
Shu-Tian ChenDepartment of Respiratory Care, Chang Gung University of Science and Technology, No. 2, Sec. West, Jiapu Rd., Puzi City 613, Chiayi County, Taiwan.ORCID 0000-0003-2650-3338
Ming-Feng TsaiDepartment of Nuclear Medicine, Chang Gung Memorial Hospital, Chiayi Branch, No. 6, Sec. West, Jiapu Rd., Puzi City 613, Chiayi County, Taiwan.
Ming-Szu HungDepartment of Respiratory Care, Chang Gung University of Science and Technology, No. 2, Sec. West, Jiapu Rd., Puzi City 613, Chiayi County, Taiwan.
Chang Gung University of Science and Technology · TWChiayi Chang Gung Memorial Hospital · TWChang Gung University · TWTzu Chi University · TW

Funding

Department of Medical Research of Chang Gung Memorial Hospital grant number CMRPG6B0191
6 · The paper itself

Abstract

This study aims to investigate the role of

Indexed as

18F-FDG PETadenocarcinoma of lungearly response evaluationsurvivaltyrosine kinase inhibitors

Identifiers

PMID35326662
PMCPMC8945925
OpenAlexW4221049329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.